'Nature biotechnology' presentation slideshows

RNA- seq ????????

736 views • 57 slides

IntAct

IntAct. A database of Molecular Interactions. Steve Jupe ( sjupe@ebi.ac.uk ). What are protein-protein interactions?. What data are we dealing with ?. Example technique: yeast two hybrid. What data are we dealing with ?. Why are we interested in Interactions ?.

745 views • 49 slides

Challenges and Methods in Transmembrane Protein Structure Determination Connie Jeffery University of Illinois at Chica

Challenges and Methods in Transmembrane Protein Structure Determination Connie Jeffery University of Illinois at Chicago cjeffery@uic.edu. Outline. 1. Importance of Transmembrane Proteins 2. General Topologies 3. Methods (and challenges) for Structural Studies of TM Proteins

844 views • 44 slides

Transdermal Delivery Systems

Transdermal Delivery Systems. Advantages of Transdermal Delivery Systems. Reasonably constant dosage can be maintained (as opposed to peaks and valleys associated with oral dosage) First pass metabolism in the liver and GI tract is avoided

1.06k views • 39 slides

Clinical Trial Authorisation in Germany for First-in-Man Trials with NCEs

Clinical Trial Authorisation in Germany for First-in-Man Trials with NCEs. Thomas Sudhop, MD Presented by Christian Steffen, MD Federal Institute for Drugs and Medical Devices (BfArM) Germany. The TeGenero Incident. Trial Design.

1.68k views • 36 slides

Clinical Trial Authorisation in Germany for First-in-Man Trials with NCEs

Clinical Trial Authorisation in Germany for First-in-Man Trials with NCEs. Thomas Sudhop, MD Presented by Christian Steffen, MD Federal Institute for Drugs and Medical Devices (BfArM) Germany. The TeGenero Incident. Trial Design.

579 views • 36 slides

A highly abbreviated introduction to proteomics

A highly abbreviated introduction to proteomics. A typical shotgun proteomics experiment. Collect tens of thousands of MS/MS spectra Can identify >1,000 proteins from cell lysate. Orbi video: http://apps.thermoscientific.com/media/SID/LSMS/Video/webinar/orbitrap_elite/animation/.

410 views • 30 slides

QA/QC of SELDI Data in Clinical Studies

QA/QC of SELDI Data in Clinical Studies. 6-8-2006 CAMDA. Simon Lin Northwestern University. CDC Toni Whistler Suzanne Vernon Northwestern Pan Du Warren Kibbe Simon Lin. Duke Radiology Ned Patz Mike Campa Duke Bioinformatics Patrick McConnell Rich Haney Sal Mungal.

335 views • 22 slides

504 views • 20 slides

Treatment Strategies for

Treatment Strategies for. Carla M. Nester MD, MSA Assistant Professor Director, Pediatric Glomerular Disease Clinic University of Iowa 28 September, 2012 1 st International Symposium on AKI in Children. DISCLOSURE STATEMENT .

291 views • 19 slides

195 views • 19 slides

SOURCE: World Development Report 2008: Agriculture for Development. World Bank, October 2007.

252 views • 11 slides

Welcome to a Presentation by Union Graduate College

188 views • 6 slides

SFO ??? stocks

SFO, the Official Advocate for Personal Investing, is dedicated to providing investors and retail traders an educational resource in the ever-changing financial marketplace. The magazine is a place for active traders to find consistently useful and cutting-edge articles on markets, trading strategies and technical methods, as well as economic and regulatory issues. The focus on global and national news, commentary and methodologies in both equities and derivatives markets offers information readers can use to shape their personal investing styles and make the most of market opportunities. The content within the high-quality pages of SFO can't be found anywhere else.

582 views • 3 slides

Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins

Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins. Bernd Wollscheid et al. Presenting by Chuan- Yih , Yu. VOLUME 27 NUMBER 4 APRIL 2009 NATURE BIOTECHNOLOGY.

128 views • 2 slides

PCSK9 Inhibitors in Development

PCSK9 Inhibitors in Development. mAb = monoclonal antibody Sheridan C. Nature B iotechnology. December 12, 2013; V31:1058.

973 views • 1 slides